Fighting blindness with a minimally invasive retinal stimulator

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/GNT1120664

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Retinal degenerative conditions are the leading cause of blindness in developed nations, with over 200 million people afflicted worldwide. Our group has pioneered a minimally-invasive therapeutic stimulator that can arrest retinal degeneration without blocking vision. We are now ready to perform the prerequisite translational studies to develop and test a human-grade device. The ultimate goal is to be the first to develop a commercial therapeutic stimulator that protects against vision loss.

Funded Activity Details

Start Date: 01-01-2017

End Date: 01-01-2020

Funding Scheme: Development Grants

Funding Amount: $998,194.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Ophthalmology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

implants | neuroprotection | retinal disease | retinitis pigmentosa | safety

Related Links